SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002002698-23-000168
Filing Date
2023-12-21
Accepted
2023-12-21 16:34:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3492
  Complete submission text file 0002002698-23-000168.txt   5279
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Subject) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 144 | Act: 33 | File No.: 001-38042 | Film No.: 231505793
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ARROWHEAD RESEARCH CORPORATION 201 SOUTH LAKE AVENUE, SUITE 703 PASADENA CA 91101
Business Address
Anzalone Christopher Richard (Reporting) CIK: 0001423029 (see all company filings)

Type: 144